Evidence map›Paper›PMID 42337056›Full record

ArticleGenes and immunity2026

Neutrophil extracellular traps formation driven by novel ELANE mutations in cyclic neutropenia patients.

Magdalena Rutkowska-Zapała, Adrianna Gałuszka-Bulaga, Jacek Plewka, Marzena Lenart, Anna Kluczewska, Marta Surman, Karolina Bukowska-Strakova, Monika Rygielska, Izabela Siemińska, Katarzyna Baran and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Magdalena Rutkowska-Zapała *Department of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.ORCID http://orcid.org/0000-0002-0923-7536
Adrianna Gałuszka-Bulaga *Department of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
Jacek PlewkaDepartment of Crystal Chemistry and Crystal Physics, Faculty of Chemistry, Jagiellonian University, Krakow, Poland.
Marzena LenartDepartment of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
Anna KluczewskaDepartment of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
Marta SurmanDepartment of Clinical Immunology, Children's University Hospital, Krakow, Poland.
Karolina Bukowska-StrakovaDepartment of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
Monika RygielskaDepartment of Pediatric Oncology and Hematology, Hematology Laboratory, University Children's Hospital, Krakow, Poland.
Izabela SiemińskaDepartment of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
Katarzyna BaranFaculty of Pharmacy, Jagiellonian University Medical College, Krakow, Poland.
Joanna CichyDepartment of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
Joanna Skrzeczyńska-MoncznikDepartment of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
Jarosław BaranDepartment of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
Maciej SiedlarDepartment of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland. misiedla@cyf-kr.edu.pl.
Anna SzaflarskaDepartment of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland. anna.szaflarska@uj.edu.pl.ORCID http://orcid.org/0000-0001-5887-4251

Funding

Narodowe Centrum Nauki (National Science Centre) 2024/08/X/NZ3/01003
6 · The paper itself

Abstract

Cyclic neutropenia (CyN) is a rare haematological disorder most often caused by mutations in the neutrophil elastase gene (ELANE). We describe three novel ELANE mutations in CyN patients and link them to impaired neutrophil extracellular trap (NET) formation. ELANE sequencing was performed using the Sanger method, and AlphaFold2 was used to visualize the impact of mutations on the structure of neutrophil elastase (NE). NET formation was assessed by colocalization of MPO, NE, and DNA using fluorescence microscopy, and free DNA was quantified fluorometrically. We identified two missense substitutions (M66K, V133G) and one deletion (G192-G196del). These mutations did not significantly alter the overall NE structure but exhibited functional effects: M66K may disrupt substrate binding, V133G increases protein mobility, and the Deletion of G192-G196 may limit the opening of the catalytic pocket. NETosis was impaired in CyN patients compared with controls. Their NETs appeared less expanded, and DNA release into supernatants was reduced, reaching the lowest levels during neutropenia, even in patients with normal neutrophil counts. These abnormalities were accompanied by reduced NE activity. In sum, novel ELANE variants may contribute to altered NE function and defective NET formation in CyN, suggesting that impaired NETosis is partly independent of cyclic changes in neutrophil numbers.

Indexed as

Extracellular TrapsLeukocyte ElastaseMutationNeutropeniaNeutrophilsFemaleHumansMaleMutation, MissenseELANE protein, humanLeukocyte Elastase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.